The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
Open accessAbstract
Serum samples from patients with meningococcal disease were examined for the presence of IL-6, TNF-alpha, and LPS. Median serum concentration of IL-6 was 1,000 times higher in patients with septic shock (189 ng/ml) than in patients with bacteriaemia, meningitis, or combined septic shock and meningitis. 11 of 21 patients with serum levels greater than 3.0 ng/ml died, whereas all 58 patients with serum levels at less than or equal to 3.0 ng/ml, survived. All four patients with serum IL-6 levels greater than 750 ng/ml, died. IL-1 was detected in serum from three patients who also had high serum levels of IL-6, TNF-alpha, and LPS, and rapidly fatal courses. IL-6 appeared to be released into serum later than TNF-alpha, and was detected in serum for up to 36 h. The half-life of IL-6 and TNF-alpha was calculated to be 103 +/- 27 min and 70 +/- 11 min, respectively. These data indicate that a complex pattern of cytokines exists in serum from patients with meningococcal septic shock, and that the release of IL-6 and IL-1, in addition to TNF-alpha, is associated with fatal outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
Le, J., & Vilček, J. (1987) · PubMed · Cited by 1,327
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,243
Self-citationWaage, A., Halstensen, A., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,096
Self-citationProduction of hybridoma growth factor by human monocytes
Aarden, L. A., De Groot, E. R., Schaap, O. L., & Lansdorp, P. M. (1987) · European Journal of Immunology · doi:10.1002/eji.1830171004 · Cited by 1,092
Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J. N., Halvorsen, S., & Sorensen, E. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.195 · Cited by 553
Self-citationMultiple actions of interleukin 6 within a cytokine network
Wong, G. G., & Clark, S. C. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91200-5 · Cited by 529
The role of cachectin/TNF in endotoxic shock and cachexia
Ceramil, A., & Beutler, B. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91353-9 · Cited by 328
Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.
van Oers, M. H. J., Heyden, A., & Aarden, L. A. (1988) · PubMed · Cited by 267
Cited by
Items 101–120 of 120
Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality
Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Brevé, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., & Kuiper, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009915200 · Cited by 186
The soluble interleukin 6 receptor: advanced therapeutic options in inflammation
Rose‐John, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.782 · Cited by 169
Periodontal therapy and cardiovascular risk
Orlandi, M., Graziani, F., & D'Aiuto, F. (2020) · Periodontology 2000 · doi:10.1111/prd.12299 · Cited by 155
Gupta, S., Hirota, M., Waugh, S. M., Murakami, I., Suzuki, T., Muraguchi, M., Shibamori, M., Ishikawa, Y., Jarvis, T. C., Carter, J. D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532580 · Cited by 151
“Under some acute inflammatory conditions, IL-6 concentrations in plasma can dramatically increase from picograms/ml to micrograms/ml (11).”
BackgroundKatsume, A., Saito, H., Yamada, Y., Yorozu, K., Ueda, O., Akamatsu, K.-I., Nishimoto, N., Kishimoto, T., Yoshizaki, K., & Ohsugi, Y. (2002) · Cytokine · doi:10.1006/cyto.2002.2012 · Cited by 134
Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis
Raffatellu, M., Chessa, D., Wilson, R. P., Tükel, C., Akçelik, M., & Bäumler, A. J. (2006) · Infection and Immunity · doi:10.1128/iai.74.1.19-27.2006 · Cited by 123
Huggins, M. A., Sjaastad, F. V., Pierson, M., Kucaba, T. A., Swanson, W., Staley, C., Weingarden, A. R., Jensen, I. J., Danahy, D. B., Badovinac, V. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.028 · Cited by 114
Inflammation and reactivation of latent herpesviruses in older adults
Bennett, J. M., Glaser, R., Malarkey, W. B., Beversdorf, D. Q., Peng, J., & Kiecolt-Glaser, J. K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.007 · Cited by 118
Rensen, P. C., Oosten, M., Bilt, E., Eck, M., Kuiper, J., & Berkel, T. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119427 · Cited by 113
“VLDL and chylomicrons were able to protect mice and rats against a lethal dose of endotoxin (20, 21), and significantly reduced the serum levels of TNF.”
BackgroundInfluentialBiologic Control of Injury and Inflammation: Much More than Too Little or Too Late
Guirao, X., & Lowry, S. F. (1996) · World Journal of Surgery · doi:10.1007/s002689900069 · Cited by 102
Repp, R., van Ojik, H. H., Valerius, T., Groenewegen, G., Wieland, G., Oetzel, C., Stockmeyer, B., Becker, W., Eisenhut, M., Steininger, H., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601367 · Cited by 88
“Cytokines, tumour markers, and plasma HER-2/neu levels Plasma – separated and stored as described above – was analysed for levels of interleukin (IL)-1a, IL-1b, IL-2, IL-6, IL-10, IFN-g, tumour necrosis factor alpha (TNF-a), G-CSF, soluble IL-2 receptor (sIL-2R), CEA, CA125, and CA15.”
BackgroundInfluentialEndotoxin Stimulates Hepatocyte Interleukin-6 Production
Panesar, N., Tolman, K., & Mazuski, J. E. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5648 · Cited by 56
Levine, J. S., Subang, R., Nasr, S. H., Fournier, S., Lajoie, G., Wither, J., & Rauch, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6504 · Cited by 51
Ramilo, O. (1990) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1990.02150270099034 · Cited by 51
Herold, R., Schroten, H., & Schwerk, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215393 · Cited by 48
AI Advances in ICU with an Emphasis on Sepsis Prediction: An Overview
Stylianides, C., Nicolaou, A., Sulaiman, W. A., Alexandropoulou, C.-A., Panagiotopoulos, I., Karathanasopoulou, K., Dimitrakopoulos, G., Kleanthous, S., Politi, E., Ntalaperas, D., et al. (2025) · Machine Learning and Knowledge Extraction · doi:10.3390/make7010006 · Cited by 28
“In healthy individuals, IL-6 ranges from 0 to 7 pg/mL [76], while IL-6 of more than 1 µ g/mL is indicative of septic shock [76].”
Sobotta, S., Raue, A., Huang, X., Vanlier, J., Jünger, A., Bohl, S., Albrecht, U., Hahnel, M. J., Wolf, S., Mueller, N. S., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00775 · Cited by 28
“High IL-6 levels are also frequently found and correlate with poor outcome in patients with sepsis, an acute systemic inflammatory response (Waage et al., 1989; Calandra et al., 1991; Damas et al., 1992; Norrby-Teglund et al., 1995).”
BackgroundSheikhi, K., Ghaderi, S., Firouzi, H., Rahimibarghani, S., Shabani, E., Afkhami, H., & Yarahmadi, A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1517369 · Cited by 20
Klein, C., Medina, E., Sander, L., Dierssen, U., Roskams, T., Mueller, W., Trautwein, C., & Goldmann, O. (2007) · The Journal of Infectious Diseases · doi:10.1086/520090 · Cited by 11
Trinh, B., Peletier, M., Simonsen, C., Plomgaard, P., Karstoft, K., Pedersen, B. K., van Hall, G., & Ellingsgaard, H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac239 · Cited by 7
Metadata
- Authors
- Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1989-01-01
- Volume
- 169
- Issue
- 1
- Pages
- 333-338
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2142585662
- Cited by
- 1,173
- References
- 15
- FWCI
- 71.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.